Urinary Incontinence
📧 Sign up to get email alerts when something new happens for Urinary Incontinence.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-05-29Clinical Trial Update: Oral vs Intravesical Analgesia for Office Bladder Botox Injections [Phase 4]
A Phase 4 trial comparing oral versus intravesical analgesia for office-based bladder Botox injections in overactive bladder conditions is u…
-
FDA approval · 2020-05-26FDA Approved: VESICARE LS — Original Application (Astellas Pharma US, Inc.)
FDA approved Vesicare LS (solifenacin succinate) under an original NDA from Astellas Pharma US, Inc. for the treatment of overactive bladder…
-
FDA approval · 2020-05-19FDA Approved: TOLTERODINE TARTRATE — Original Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s original application for tolterodine tartrate (generic tolterodine tartrate), a treatment for overacti…
-
CLINICAL_TRIALS trial_result · 2020-05-14Clinical Trial Update: Combined Treatment for Mixed Incontinence [Phase 3]
Phase 3 clinical trial of a combined treatment for mixed urinary incontinence has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: A Long-Term Extension Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity [Phase 3]
A long-term extension study of onabotulinumtoxinA (BOTOX) for urinary incontinence due to neurogenic detrusor overactivity has completed Pha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-04-06FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (Leading Pharma, LLC)
FDA approved Leading Pharma, LLC's original Abbreviated New Drug Application for oxybutynin chloride, enabling a generic version of this ant…
-
FDA approval · 2020-03-13FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for oxybutynin chloride from Amneal Pharmaceuticals LLC, updating the approval of the existing gener…
-
FDA approval · 2020-03-09FDA Approved: TOLTERODINE TARTRATE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Tolterodine tartrate (Tolterodine) by Torrent Pharmaceuticals Limited.
-
FDA approval · 2020-02-28FDA Approved: OXYBUTYNIN CHLORIDE EXTENDED RELEASE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for an extended-release formulation of oxybutynin chloride, manufactured by Rising Pharma Holdings, …
-
FDA approval · 2020-02-28FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for oxybutynin chloride from Ajanta Pharma USA Inc., authorizing the generic oxybutynin chloride pro…
-
CLINICAL_TRIALS trial_result · 2019-12-24Clinical Trial Update: Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence [Phase 4]
Phase 4 trial evaluating an alternative injection paradigm for onabotulinumtoxinA (BOTOX) in overactive bladder with urinary incontinence ha…
-
CLINICAL_TRIALS trial_result · 2019-12-02Clinical Trial Update: Incontinence & Intimate Partners: Assessing the Contribution of Treatment [Phase 4]
Phase 4 clinical trial assessing the contribution of treatment for urge urinary incontinence; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-14Clinical Trial Update: Clinical Trial of Autologous Adipose Derived Regenerative Cells for the Treatment of Male Stress Urinary Incontinence [Phase 3]
A Phase 3 clinical trial evaluating autologous adipose-derived regenerative cells for male stress urinary incontinence has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Controlled Trial of Tele-Support and Education for Womens Health Care in CBOCs
Clinical trial update on a tele-support and education program for women's health care in community-based outpatient clinics (CBOCs); study c…
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients [Phase 3]
Phase 3 clinical trial evaluating onabotulinumtoxinA (BOTOX) for urinary incontinence due to neurogenic detrusor overactivity in pediatric p…
-
CLINICAL_TRIALS trial_result · 2019-09-18Clinical Trial Update: Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery [Phase 3]
Phase 3 trial assessing robot-assisted radical prostatectomy and its effect on short-term continence recovery after surgery.
-
FDA approval · 2019-09-09FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for oxybutynin chloride submitted by Chartwell RX, LLC. The approval confirms continuation of the ge…
-
FDA approval · 2019-08-19FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for oxybutynin chloride from Amneal Pharmaceuticals LLC.
-
FDA approval · 2019-08-19FDA Approved: OXYBUTYNIN CHLORIDE EXTENDED RELEASE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for oxybutynin chloride extended-release filed by Rising Pharma Holdings, Inc. This approval mak…
-
FDA approval · 2019-08-13FDA Approved: FESOTERODINE FUMARATE — Original Application (Dr.Reddy's Laboratories Inc.,)
The FDA approved fesoterodine fumarate from Dr. Reddy's Laboratories Inc. via an original ANDA for the treatment of overactive bladder sympt…
-
CLINICAL_TRIALS trial_result · 2019-07-26Clinical Trial Update: Comparative Study of PDVF and Polypropylene Transobturator Suburethral Tapes [Phase 4]
Phase 4 comparative trial of PDVF and polypropylene transobturator suburethral tapes for urinary stress incontinence has completed.
-
CLINICAL_TRIALS trial_result · 2019-07-26Clinical Trial Update: A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting [NA]
Pilot clinical trial in nursing homes evaluating TENA Identifi for urinary incontinence has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-19Clinical Trial Update: Lidocaine for Pain After Urodynamic Testing [Phase 4]
Phase 4 clinical trial evaluating lidocaine for pain relief following urodynamic testing.
-
CLINICAL_TRIALS trial_result · 2019-06-06Clinical Trial Update: Effect of Electroacupuncture Versus PFMT Plus Solifenacin for Mixed Urinary Incontinence [NA]
Clinical trial comparing electroacupuncture to PFMT plus solifenacin for mixed urinary incontinence has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Treatment of Incontinence Without Memory Problems [Phase 4]
Phase 4 clinical trial update on treatment for urge urinary incontinence with no memory problems; results posted after completion.